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Director: Christian Zemlin 
In this thesis, we present new engineering approaches to several important cardiac 
diseases. Chapter 1 considers the dynamics of arrhythmias.  The most dangerous 
arrhythmias are reentrant arrhythmias, including ventricular fibrillation and ventricular 
tachycardia.  During these arrhythmias, there are one or several rotating excitation waves 
present in the heart.  Because of their shape, these waves are called scroll waves; their 
center of rotation is a one-dimensional curve called the filament.  Filaments largely 
constrain the configuration of a scroll wave but are much simpler, so much effort has 
gone into describing scroll wave dynamics in terms of the dynamics of their filaments.  In 
particular, the “geodesic principle” for filaments, which says that stable filaments are 
geodesics in a metric derived from the diffusivity, has been proposed and established for 
certain restrictive conditions.  In this project, we show that the geodesic principle applies 
much more broadly, including for very large filament curvatures. We also discuss under 
which conditions the geodesic principle fails, particularly the case that the filament gets 
close to very heterogeneous substrate. 
 
Chapters 2-4 introduce a new approach to cardiac defibrillation. The only existing 




the heart using a defibrillator to terminate fibrillation and restore organized rhythm. 
Defibrillators currently available are effective in treating ventricular fibrillation, however, 
because of the large amount of energy deposited during the treatment can cause 
damaging effects to the tissue. In this project, we present results of a new technology 
using nanosecond pulsed electric fields to defibrillate the heart, while depositing only a 
fraction of energy needed by conventional defibrillators. 
 
In the final part of this thesis, Chapters 5-7, we present results of an injectable therapeutic 
agent to regenerate the myocardium (heart muscle) affected by infarction. Myocardial 
infarction is a serious coronary artery disease that occurs when a coronary artery is so 
severely blocked that there is a dramatic reduction or complete disruption of blood 
supply, causing damage or death to the territory of the myocardium that was supplied by 
the blocked coronary vessel. Our results show how the injection of the therapeutic agent 
helps in preserving the electrical activity in the affected area, and also reduces 
pathological effects on the ejection fraction and heart rate. 
 
In summary, we contribute to the understanding of the mechanisms of reentrant 
arrhythmias, develop new technology for ventricular defibrillation, and test a therapeutic 
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INTRODUCTION: DYNAMICS OF ARRHYTHMIAS 
The basic properties of cardiac tissue that permits impulse propagation are that cells have 
a stable resting state and that excitation can be induced with a sufficiently strong 
stimulus; this excitation can then propagate to resting neighboring cells.  This property is 
called “excitability”, and it is shared by many other media besides the heart; they are 
called “excitable media”. 
 
Phenomena such as the amoeba aggregation[1], transmission of impulses between 
neurons[2], and cardiac arrhythmias[3], can all be understood using the framework of 
excitable media[4].   An excitable medium is a continuous set of locally excitable entities 
like cardiac cells that can be stimulated independently[5]. These entities exhibit a 
threshold below which the media remains undisturbed in a stable state while any 
stimulation greater than the threshold will induce local transformation within the 
media[5].   
 
Three-dimensional excitable media can maintain organized activity in the form of 
rotating, scroll-shaped waves. Scroll waves have been observed in a wide range of 
excitable media[6]–[10], most notably in the heart, where they cause life-threatening 
arrhythmias[11]–[13]. They are organized around vortex-like cores, called filaments, that 




can also become anchored (pinned), giving rise to stationary rotating scroll waves[17]–
[19] which in the heart are linked to sustained arrhythmias.  
 
Excitable media are governed by reaction-diffusion equations.  The diffusion coefficient 
is one of the key parameters, defining the propagation velocity of the excitation 
wave[20]. In models of the heart, diffusion is described by a tensor, which represents the 
anisotropic electrical conductance of muscle fibers constituting the myocardial wall[21].  
 
Here we focus of on the shape and the dynamics of anchored filaments in media with a 
discontinuous change in diffusion. In the heart, such discontinuities correspond to abrupt 
changes in fiber direction, which are characteristic of the outflow tract[22] and other 
regions of the myocardium[23].  These regions are linked to arrhythmias[24], but their 
mechanism remains largely unknown, which makes the investigation of the filament 
properties in media with discontinuities in diffusion particularly important.  
 
We show that a discontinuity in diffusion makes the filament abruptly change its angle to 
the interface, reminiscent of the refraction of a light beam at the boundary separating 
domains with different optical density. There is also a critical angle of the filament to the 
interface, which cannot be exceeded.   Using a generalized geodesic principle[18], we 
derive analytically the laws of “refraction” and test their validity computationally for 
different filament orientations. Geodesic is the shortest path that a non-accelerating 




Unlike the refraction of an optical beam, filament refraction appears to be a significantly 
more complex phenomenon manifesting unparalleled dynamic behaviors.  Specifically, at 
small angles of the filament to the interface, we discovered a diffusion-mediated filament 
instability and oscillatory regimes, in which one segment of the filament abruptly 
increases in length, overcoming positive filament tension[25],  then gradually shortens to 
erupt again after several scroll wave rotations. The instability is caused by the gradient 
force field which is present in the vicinity of the interface and manifests when the 






METHODS: DYNAMICS OF ARRHYTHMIAS 
Computational experiments were carried out numerically using reaction-diffusion 
equations with Barkley kinetics[26] :    
 
 𝜕𝑡𝑢 = 𝜀−1𝑢(1 − 𝑢)[𝑢 − (𝑣 + 𝑏)/𝑎] + 𝜕𝑗�𝐷𝑖𝑗𝜕𝑖𝑢� (1) 
  




where u and v are the activator and inhibitor variable, respectively, and the parameters ε, 
b, and a determine the excitability of the medium.   
The diffusion tensor Dij was given different values in the lower (z < 0) and upper 
(z ≥ 0) part of the medium, with a discontinuity at the interface.  Specifically, we 
considered two cases, listed in Table I: isotropic diffusion (Case I) and anisotropic 
diffusion with a π/2 rotation of D in the xy plane (Case II). In the context of cardiac 







Table I. Diffusion tensor for cases I and II. 
Case                 𝐷𝑖𝑗(𝑧𝑧 < 0)                 𝐷𝑖𝑗(𝑧𝑧 ≥ 0) 
I                   𝑑1𝛿𝑖𝑗                        𝑑2𝛿𝑖𝑗  
II              diag�𝑑1,𝑑2,𝑑2�              diag(𝑑1,𝑑2,𝑑2) 
 
The scroll wave was initiated between two hemi-spherical anchors A and B, located at the 
lower and upper boundaries of the medium. After equilibration, we slowly (quasi-
statically) increased the ratio of the diffusion coefficients (d1/d2, see Table 1), 
progressively increasing the jump in the diffusion tensor at the interface (z = 0), until it 
reached the desired value. The resulting filament had two linear segments [see Fig. 1(a)], 
whose orientation depended on d1 and d2.  To investigate the entire range of filament 
orientations with respect to the interface, we also varied the angle between the filament 
and the interface by gradually moving one of the anchors.  
 
To compute the filament location we identified the filament tube characterized by 
reduced amplitude of variable u and determined the center of the tube as described in [58]. 
We chose medium parameters 𝜀 = 0.02, a = 0.9, b = 0.05, which support stable scroll 
waves with positive filament tension[25].  Medium size was 100 x 100 x 100 nodes with 
∆x=0.25, for which plane wave speed is accurate within 3%, and no-flux boundary 







RESULTS AND DISCUSSION: DYNAMICS OF ARRHYTHMIAS 
We first apply the geodesic principle[18] to derive the shape of the stationary filament in 
Cases I and II. According to the geodesic principle, the stationary filament should follow 
the geodesic with the metric defined as:  
 𝑔𝑖𝑗 = (det𝐷)(𝐷−1)𝑖𝑗  (3) 
 
The symmetry of D requires that the stationary filament consists of two linear segments 
AC���� and CB���� at different angles α and β to the interface [see Figure. 1 (b)]. Let us denote 
the unit vectors along the segments 𝐴𝐶 and 𝐶𝐵 as 𝑎 =  �𝑎𝑥,𝑎𝑦,𝑎𝑧� for z < 0 and 
𝑏 =  �𝑏𝑥, 𝑏𝑦, 𝑏𝑧� for z > 0, respectively. 
Figure 1: Refraction of a scroll-wave filament in a medium with discontinuous diffusion 
tensor. (a) Snapshot of a scroll wave and its filament in the model given by Eqs. (1) and 
(2) (case I: d1 = 1.5, d2 = 0.5). The isosurfaces for u = 0.5 are shown in transparent gray, 




halves in transparent dark gray. The filament is noticeably thinner in the upper region 
because d2 < d1. (b) Schematic cross section through the anchor plane (y = 0) in (a), 
explaining our notations. (c) Dependency of ax on bx as derived from the geodesic 
principle (lines) and observed in numerical experiments (symbols) for γ = 3. (d) 
Numerical verification of Eqs. (6) and (7) for fixed anchor positions and varying γ. 
 
Case I. To find the relationship between α and β, we assume without loss of generality 
that both anchors are located in the plane y = 0.  Then, the isotropy of D requires that the 
whole filament stays in this plane(𝑎𝑦 =  𝑏𝑦 = 0). From Eq. 3 we find the metric tensor 
𝑔𝑖𝑗 for this case:  
 
𝑔𝑖𝑗 =  �
(𝑑1)2𝛿𝑖𝑗           for 𝑧𝑧 < 0





The geodesic condition then can be written as  
 








  (5) 
 
from which we obtain the relationship between angles of the upper and lower segments of 














Equation (6) is reminiscent of Snell's law for light refraction, with the diffusivities 
playing the role of refraction indices (this filament refraction is markedly different from 
the refraction of excitation fronts, which follows the tangent rule[27] ).   
 
Case II. For simplicity, we again assume that 𝑎𝑦 =  𝑏𝑦 = 0.  By applying the geodesic 
principle, we find that  𝑎𝑥 can be expressed as the following function of  𝑏𝑥: 
 
𝑎𝑥 =  
𝑏𝑥
𝛾 (1 − 𝑏𝑥




where 𝛾 =  𝑑1 𝑑2.⁄   A full technical derivation of this and a more general case of arbitrary 
fiber rotation will be presented in a future publication. Note that asymptotically at small 
 𝑏𝑥, Eq. 7 coincides with Eq. 6. 
 
As in the case of light refraction, Eqs. 6 and 7 imply the existence of critical angles αc for 
which 𝛽 =  𝜋 2⁄  (𝑏𝑥 = 1). In the context of this study, this means that independently of 
the anchor's position, the filament will always adapt its shape in such a way that 𝛼𝛼 ≤
 𝛼𝛼𝑐𝑐.  For Case I, 𝛼𝛼𝑐𝑐 = arcsin(𝛾−1). while for Case II,  𝛼𝛼𝑐𝑐 = arcsin�𝛾−1 2⁄ �. The solid 
lines in Figs. 1(c) and 1(d) show the dependence of  𝑎𝑥 on  𝑏𝑥 and of the ratio  𝑎𝑥/ 𝑏𝑥 on 
γ predicted from Eqs. (6) and (7).  
 
To test the validity of Eqs. (6) and (7), we carried out numerical experiments using the 
full model Eqs. (1) and (2). The values of  𝑎𝑥  and  𝑏𝑥 were calculated from the filament 




medium, respectively. The simulation results were superimposed onto the theoretical 
plots (see Figures 1(c) and 1(d)).  In both series of computational experiments we 
observed excellent agreement with theory.  
 
While holding rather well in a broad range of parameters, the theoretical predictions start 
failing when 𝛼𝛼 → 𝛼𝛼𝑐𝑐 and  𝛽 →  𝜋 2⁄ .  The deviations were most pronounced in Case I.  
Figure 2 shows the evolution of the filament as the distance of the anchor B from the 
interface (𝑧𝑧𝐵𝐵) gradually decreases. At larger 𝑧𝑧𝐵𝐵 [see Panel (a)], the filament consisted of 
two rectilinear fragments, in excellent agreement with the theory. When 𝑧𝑧𝐵𝐵 is reduced 
from 0.77𝜆𝜆𝑧 to 0.26𝜆𝜆𝑧, however, the upper segment of the filament deviated from the 
geodesic and became noticeably curved [see Fig. 2(b)].  
 
As the anchor continued to approach z = 0, the deformation increased, and the respective 
fragment of the filament started oscillating [Figures 2(c)].  The oscillation cycle consisted 
of two distinct phases: 1) rapid bulging and moving away from the interface, and 2) slow 
straightening and approaching the interface. The two filament positions shown in Panel 
(c) represent these two phases. The period of filament oscillations was more than an order 
of magnitude longer than that of the rotation of the scroll wave.  Further reduction in 𝑧𝑧𝐵𝐵 
increased the amplitude of oscillation and caused the detachment of the filament from the 
upper anchor. Attached only at the bottom end, the filament started clockwise precession 







It is interesting that during these transformations, the filament shape remained close to 
the geodesic solution. Indeed, the lower segment of the filament remained rectilinear 
with 𝛼𝛼 =  𝛼𝛼𝑐𝑐. The ratio sin(𝛽) sin(𝛼𝛼)⁄  remained close to γ as prescribed by Eq. (6) (we 
used linear regression to approximate the curved filament and compute 𝛽). The 
Figure 2: Filament snapshots (lateral and top views) at different anchor positions in 
case I, with d1 = 1.5, d2 = 0.5, (γ = 3). The values of 𝑧𝑧𝐵𝐵 indicate the distance of the 
anchor B from the interface in units of 𝜆𝜆𝑍𝑍, the wavelength of the scroll wave in the z 
direction. (a) Filament refraction consistent with the geodesic principle. (b) The upper 
segment of the filament becomes curved. (c) The filament begins to oscillate in the 
vicinity of the geodesic solution. (d) The filament detaches from anchor B and rotates 
in the clockwise direction. The numbers show consecutive filament configurations 




deviations from the geodesics were less pronounced in case II than in case I (see Figure 
3). Within the range of parameters studied, we did not observe any oscillations and the 
filament remained attached to the lower anchor all the way to z = 0.  
 
The milder deviations from the theory in case II are due to the fact that in this case only 
two components of the diffusion tensor change at the interface, as opposed to all three in 
case I. It would be reasonable to expect that in a generalized case II with fiber rotation at 
the interface of less than 𝜋 2⁄ , the deviation from the theory will be even smaller.  
 Figure 3: Refraction and “reflection” of the filament in case II (γ = 3). Notations as in 
Figure 2. (a) The filament consists of two rectilinear fragments consistent with 
geodesic predictions. (b) At 𝛼𝛼 close 𝛼𝛼𝑐𝑐, the upper segment of the filament runs almost 
parallel to the interface. (c) As the anchor B moves below the interface, the filament 
folds and produces an additional linear segment at an angle close to 𝛼𝛼𝑐𝑐, reminiscent of 




In case II, we observed a phenomenon reminiscent of internal reflection [Figure 3c)].  
When we moved the second anchor across the interface to the lower half of the medium, 
we obtained a filament with 3 segments: The first segment at an angle α close to 𝛼𝛼𝑐𝑐, the 
second approximately parallel to the interface, and the third again at an angle close to 𝛼𝛼𝑐𝑐, 
(a distant analogy to optical total reflection). When the length of the central fragment 
became very small, the filament detached from the interface and acquired a rectilinear 
shape [Figure 3(d)].   
 
The deviations of the filament shape from the geodesic and the complex filament 
dynamics at small angles to the interface are the result of a short-range force 𝐹𝐹𝑏𝑏 which 
affects the filament in the vicinity of the boundary separating regions with different 
diffusion [see Figure 4a]. Such a force is present at any boundary separating domains 
with different parameters[28] . In our case, 𝐹𝐹𝑏𝑏(𝑧𝑧) ∝  |𝑛 × 𝑏|, where n is the normal to the 
interface pointing in the direction of greater diffusivity.  By analogy with two-
dimensional cases[28], [29], it is reasonable to expect that the spatial range of 𝐹𝐹𝑏𝑏  is of 
the order of the filament radius, 𝑤𝑤 =  𝜆𝜆𝑧/2𝜋. Parts of the filament located outside the 
boundary layer defined by 𝑤𝑤 remain unaffected by 𝐹𝐹𝑏𝑏 [see Figure 4(a)].  
 
The portion of the filament experiencing 𝐹𝐹𝑏𝑏 is therefore 𝑤𝑤/𝑧𝑧𝐵𝐵.  For small β the affected 
portion is small and has little effect on the filament angle.  As β increases, so does 𝑤𝑤 𝑧𝑧𝐵𝐵⁄ , 
until the entire segment 𝐶𝐵 is affected (𝑤𝑤 𝑧𝑧𝐵𝐵 = 1⁄ ) as β approaches 𝜋 2 ⁄ . 𝐹𝐹𝑏𝑏 makes the 
filament drift, while the anchor prevents the end of the filament from moving. This 




curvature-related normal and binormal forces which contribute to subsequent filament 
dynamics[17]. 
 
Figure 4 (a) Schematic illustrating the mechanism of filament deformation at 
small 𝑧𝑧𝐵𝐵. The portion of the filament inside the boundary layer of width w 
experiences a force 𝐹𝐹𝑏𝑏, which pulls it off the xz plane, creating a bulge as 
indicated by the dashed line. (b) Deviation of the upper filament segment from the 
straight line as a function of  𝑤𝑤/𝑧𝑧𝐵𝐵 (case I, γ = 3). Deviation was quantified by 
determining the distance between the predicted and actual filament coordinates in 
each cross section (yz plane) of the medium and then calculating the root-mean-
square deviation. The width of the hatched area indicates the amplitude of 
oscillations. The dashed vertical line indicates the detachment of the filament 




Figure 4 (b) shows the average deviation of the filament from straight line as a function 
of 𝑤𝑤 𝑧𝑧𝐵𝐵⁄  for case I.  Indeed, the deviation is small when 𝑤𝑤 𝑧𝑧𝐵𝐵⁄  ≪ 1 and dramatically 
increases as 𝑤𝑤 𝑧𝑧𝐵𝐵⁄  approaches 1. Oscillations start as 𝑤𝑤 𝑧𝑧𝐵𝐵⁄  ≈ 0.63, whereas complete 
detachment occurs at 𝑤𝑤 𝑧𝑧𝐵𝐵⁄  ≈ 0.67.  The gradual rise of oscillation amplitude suggests 
that the bifurcation is supercritical, while the narrow range of 𝑤𝑤 𝑧𝑧𝐵𝐵⁄  in which we see 
deviations is likely the result of the strong dependence of 𝐹𝐹𝑏𝑏 on z. 
 
Our findings have important implications with regard to utility of geodesic principle[30], 
[31].  The geodesic principle enables the prediction of the shape of the stationary filament 
exclusively from the diffusion tensor, without considering the kinetic parameters of the 
medium.  The validity of the geodesic principle was proven only for small filament 
curvatures[32]  which limited its practical application. Our study shows that for practical 
purposes, with the exceptions mentioned above, the requirement of small filament 
curvature can be relaxed. Computer simulations clearly show that despite significant 
curvature of the filament near the interface, its shape remains consistent with the geodesic 
predictions. Considering that this study focuses on the most extreme case of 
discontinuous diffusion, it is reasonable to expect that the agreement will be even better 









In summary, we demonstrated that an anchored filament refracts at the boundary 
separating domains with abruptly changing diffusivity tensor. In the particular case of 
domains with isotropic diffusion, the refraction law is reminiscent of Snell's law in 
geometrical optics. We showed that the condition of small filament curvature used for the 
derivation of the minimal principle for practical purposes can be relaxed, which 
significantly extends the utility of the geodesic approximation. Finally, we discovered 
oscillatory regimes, and instabilities resulting from abrupt changes in anisotropy that shed 
new light onto the role of the abrupt changes of anisotropy in the development and 











NANOSECOND PULSED ELECTRIC FIELD (NSPEF) DEFIBRILLATION IN 






INTRODUCTION: NsPEF DEFIBRILLATION IN RABBIT HEART 
Annually, about 300,000 deaths in the United States occur due to ventricular fibrillation 
(VF)[33]. The only effective treatment is to deliver high amplitude electric shocks to the 
heart trans-thoracically using a defibrillator to terminate fibrillation and restore organized 
rhythm.  During the normal cardiac rhythm, action potentials generated by the sinoatrial 
(SA) node travel through the atria by cell-to-cell conduction. As the activation travels 
across the atria, it depolarizes the atrial cells resulting in the contraction and pumping of 
blood from the atria to the ventricles[33]. The activation from the SA node reaches the 
atrioventricular (AV) node and spreads through the ventricles via a specialized 
conduction system[34]. This results in the coordinated depolarization of the ventricles 
which stimulates the contraction of the heart[35], and the electrocardiogram (ECG) of a 
normal heart is shown in Figure 5A.  
 
VF, in contrast, consists of multiple re-entrant wavelets that depolarize different parts of 
the ventricles[35], resulting in arrhythmic and ineffective contraction of ventricles[35]. 
The ECG of a VF episode is shown in Figure 5B; it is irregular with a frequency of 7-10 




Figure 6: Waveform used monophasic 
defibrillator along with the paddle 
position and direction of flow of 
current. 
 
Although the defibrillators currently used are 
effective in treating ventricular fibrillation, 
there are reports of damaging effects, like cell 
damage, pain, cardiac ectopic, tachycardia, 
arrhythmia, asystole, re-fibrillation, and even 
death  specially due to higher energy 
shocks[35], [36]. In most cases, more than 
one shock, and even up to 8 eight shocks need 
to be applied to terminate disorganized 
rhythm[37], [38].  
A 
B 
Figure 5: ECG waveforms in normal and fibrillating heart. Panel A shows the ECG 




Figure 7: Waveform used in a biphasic 
defibrillator along with the paddle position 
and bidirectional flow of current. 
In the first defibrillators, shocks were generated by discharging a capacitor across the 
thorax, so that the waveform was a truncated exponential (Figure 6).  The typical energy 
delivered during the application using a monophasic defibrillator is around 400 J[39] and 
pulse duration is between 5 and 10 ms[40].  
 
Efforts to decrease the amount of 
energy deposition during defibrillation 
resulted in the development of shocks 
with biphasic waveforms, which 
consist of two consecutive truncated 
exponentials of opposite polarity 
(Figure 7)[41]–[43]. Biphasic 
defibrillators reduced the amount of  
energy deposited during defibrillation 
by 20 to 40%, or around 100 J[41]–
[44]. Biphasic shocks are now generally regarded as superior and universally used in 
modern defibrillators[41], [42]. Several papers have tested improvements of biphasic 
waveforms to further reduce the required defibrillation energy, but achieved only 
marginal improvements and the clinical benefits of using biphasic waveforms in out-of-






4.1 NsPEF defibrillation technology 
An interesting, untested alternative to this conventional defibrillation is to apply shocks 
or trains of shocks of nanosecond duration, also called nanosecond pulsed electric fields 
(nsPEFs). NsPEFs have been used successfully in other contexts, particularly in tumor 
ablation48. In cancer research, they have also been found to be effective in apoptosis[47] 
and drug delivery[48]–[50].  
 
Nanosecond PEFs of sufficient strength (approximately 200 mV/ membrane) are known 
to cause electroporation of the plasma membrane[48]. It has been shown in individual 
cells that there is a significant range of voltage amplitudes for which electroporation is 
reversible, i.e. pores eventually reseal and the cells recover. Stronger shocks cause 
irreversible electroporation and cell death via necrosis. Compared to electroporation that 
occurs with millisecond pulses, the pores created with nsPEF are smaller[48].   
 
In the case of millisecond defibrillation, resistive currents that charge the cell membranes 
play an important role in the depolarization of the cells, while nsPEFs being so short, 
leave little time for capacitive charging and the instantaneous displacement current 
becomes more important. The greater reliance on displacement current also makes nsPEF 
defibrillation less sensitive to the presence of structural heterogeneities, so the penetration 






Nanosecond PEFs have not yet been used to stimulate or defibrillate the whole heart, but 
there are a few studies which demonstrate the ability of nsPEFs to trigger in action 
potentials in excitable cells.  In neurons, it was shown that after nsPEF stimulation, 
calcium entered the myoplasm and either triggered action potentials or modulated neural 
activity[53]. Skeletal muscle (gastrocnemius) can also be activated with nsPEFs[54]. In 
this part of the thesis, we show that nsPEF defibrillation is possible, with defibrillation 





METHODS: NsPEF DEFIBRILLATION IN RABBIT HEART 
5.1 Heart harvest 
All animal experiments in this study were conducted in accordance to an approved Old 
Dominion University Institutional Animal Care and Use Committee protocol. The studies 
were conducted in an AAALAC accredited facility. The animal was anesthetized in an 
induction chamber with 4% isofluorane. A toe pinch and ear flick test was done to 
confirm the animal was in the surgical plane of anesthesia. Once anaesthetized, the 
animal was placed in dorsal recumbence and the thoracic cavity is shaved followed by an 
injection of heparin.  The thoracic cavity was opened, exposing the heart, and the heart 
was explanted and moved to a container filled with ice-cold Tyrode solution (128.2 mM 
NaCl, 1.3 mM CaCl2 (2H2O), 4.7 mM KCl, 1.05 mM MgCl2 (6H2O), 1.19 mM 
NaH2PO4, 20 mM NaHCO3, 11.1 mM D-Glucose in deionized water, pH=7.35±0.05). 
The heart was attached to a custom-made cannula and flushed with cold Tyrode solution. 
Cold Tyrode solution helped in arresting the cardiac activity and prevented deterioration 
until it was connected to the life-support system. The cannulated heart was Langendorff-
perfused with fresh Tyrode solution and then transferred to the experimental setup. A 







5.2 Experimental setup 
Our experimental setup can be divided into the life support system the optical mapping 
setup.  
 
5.2.1 Life support system 
The life support system helps keep the heart alive. The life support system has a chamber 
that contains the Langendorff-perfused heart. The heart was also superfused with Tyrode 
solution to maintain ambient temperature at 37+/-1 degree Celsius. The Tyrode solution 
is aerated with 95% O2, adjusted to maintain pH in the range from 7.35-7.45. The pH- and 
temperature-stabilized solution is then pumped at a variable rate to maintain a pressure of 
50 to 60 mmHg in the heart. We also use an excitation-contraction decoupler, either 2, 3-
butanedione monoxime (BDM) or blebbistatin, to remove any motion artifact.  
 
5.2.2 Optical mapping system  
The optical mapping system, Figure 8, consists of laser, mirrors, diffusers, filters and a 
CCD camera. The preparation was stained with the near-infrared dye DI-4- ANBDQBS, 
with a stock solution made by dissolving 10 mg of dye in 1.2 ml of pure ethanol, made 
fresh for each experiment. From DI-4-ANBDQBS stock solution, 15 µL of dye was 
diluted in 15 mL to 20 mL of Tyrode's solution and injected as a bolus. A 1000 mW, 671 
nm diode laser (Shanghai Dream Lasers) was directed through a 5-degree conical diffusor 
and then through a dichroic mirror (λcrit=690 nm) onto the heart to achieve uniform 




Fluorescence light passed the dichroic mirror and a 715 nm long pass filter and was 
recorded with a CCD camera (“Little Joe”, SciMeasure, Decatur, GA) at 1000 frames per 
second. 
 
5.2.3 Mechanism of voltage sensitivity dyes 
Voltage-sensitive dyes have a high affinity for the cell membrane and bind to it. The 
central part of the dye molecule is the chromophore (Figure 9A), which interacts with the 
light.  Photons are absorbed when their energy matches the difference between the energy 
of the ground state of the chromophore and its excited state. 
Figure 8: Optical mapping setup consisting of heart preparation, optics and detection. In 
heart preparation, the heart is continuously perfused and superfused with body 
temperature Tyrode solution. Optics consists of laser and other optical devices to direct 





More precisely, the ground state and the excited state correspond to energy distributions; 
so that the absorption probability (also called the absorption spectrum) is a continuous 
function of wavelength (see Figure 9B). Sometime after a chromophore is excited to a 
higher energy state, it comes back to the ground state by emitting a photon 
(fluorescence).   
Voltage sensitivity of dyes are caused by the fact that the excitation involves the 
movement of a charge from one end of the chromophore to the other.  The dye molecule 
has parts on either side of the chromophore that ensure that it was oriented with its long 
axis in transmembrane direction (this is the direction in which the charge moves during 
excitation).  Since the movement of charges in electric fields requires (or yields) energy, 
this geometry makes the absorption and emission of photons by the chromophore 
sensitive to the presence of transmembrane voltage. Absorption and emission spectra 
A B 
Figure 9: Mechanism of voltage sensitive dye. Panel A shows the schematic 
representation of voltage sensitive dye molecules (inside the dotted circle). Panel B 




shift proportionally to the transmembrane voltage as it changes (Figure 9B). This means 
that for excitation and absorption of fluorescence at fixed wavelengths, the absorption 
and emission rates become linear functions of transmembrane voltage; therefore, dye 
molecules transduce the transmembrane voltage into light. 
 
5.3 Millisecond stimulation                                                                                                     
A stimulator functions as a pacemaker that can be used to pace the heart at a desired 
frequency. Normally, a rabbit heart is paced at 300 ms, with 8 to 10 ms pulse duration, 
(Grass model SM5E) using monopolar electrode. The stimulation amplitude is set at 
twice the threshold required to stimulate the heart (typically in the range of 2.5 V/cm to 3 
V/cm).  
 
5.4 Temperature measurement and regulation 
The Tyrode solution is heated and maintained at 37±1oC by multiple heat exchangers. 
The temperature is measured both in the chamber and near the cannula. Depending on the 
temperature requirements, the water bath temperatures are regulated. The temperature 
measurements are made using thermocouple elements, which are continuously sampled 







5.5 Pressure measurement and regulation 
A pressure transducer (TD1000, Transducer Direct) was connected very close to the 
aorta, and the resultant pressure signal was continuously sampled by a data acquisition 
board, displayed and recorded. The pressure was maintained between 60 to 70 mmHg 
and was regulated by adjusting the perfusate flowrate.  
 
5.6 Nanosecond pulse generation with transmission line  
The stimulation and defibrillation of heart tissue require the delivery of high amplitude 
nanosecond shocks. The ultra-short rectangular pulse generator, Figure 10, consists of a 
high voltage DC power supply, a charging resistor Rcharge to limit the charging current, a 
transmission line of length L, which acts as a capacitor, and an adjustable spark gap 
between the charging resistor and the matching resistor ZM. Once the transmission line is 
charged to the breakdown voltage, VBD, the spark gap becomes conductive and the 
capacitor discharges through the load, which is the heart. The voltage on the load V1 is 




determined by the impedance of the load Zl (matching resistor ZM parallel to the load, i.e 
cardiac tissue Ztissue) and the impedance of the transmission line, Ztl. If the impedance of 
the transmission line and the load are equal, then the voltage delivered to the load will be 
half of the breakdown voltage (VBD/2). Thus, by changing the width of the spark gap, we 
can adjust the breakdown voltage VBD, which will finally determine the amplitude of the 
rectangular pulse delivered to the cardiac tissue. 
 
The pulse duration of the rectangular pulse is equal to twice the time taken by the 
electromagnetic wave to travel the transmission line and is given by  
 











C is the velocity of the light in vacuum and 𝜀𝑟 is the relative permittivity of the dielectric 
material which insulates the transmission line. The transmission line used in our pulse 
generator is RG-58 coaxial cable with relative permittivity of √𝜀𝑟  =  1.5. To generate a 
pulse of 350 ns pulse duration, we used a coaxial cable of length L=35 m ( 350 x 3 x 108 
x 2 x 1.5). The nanosecond pulse, Figure 11, was attenuated using probe (P6015A, 
Tektronix) and was recorded using an oscilloscope (Tektronix).  In-order to generate 
rectangular shapes pulse, a matching resistor was connected in parallel to the load.  The 




of 700 V for cardiac stimulation studies while it is set in the range of 2.3 to 2.6 kV for our 
defibrillation studies. 
 
5.7 VF induction 
In our preliminary studies, inducing sustained VF was one of the most difficult 
challenges. VF was considered “sustained” if it lasted for more than 30 seconds.  Several 
articles mention that by rubbing the electrodes of a 9 V battery on the ventricles of the 
rabbit heart for 15 to 20 seconds would induce VF[55], [56]. This method was tried on 
the first four hearts, but only on a few instances was VF sustained after the battery was 
taken off. Because of the limited success of this procedure, we also tried placing the heart 
in between two plate electrodes connected to a 9 V battery. Again, VF was observed as 
long as the battery was connected but usually stopped as the battery was disconnected. 
Two other techniques that we found in the literature and tested were “burst pacing” 




(inducing VF with rapid pacing with the frequency varying from 8 Hz to 50 Hz) and 
“incremental pacing”, which starts with pacing at 2 Hz and increments every 30 seconds 
by 1 Hz.  These techniques were even less successful than induction with a 9 V battery.   
Finally, following the recommendations of Dr. Efimov, we decided to add pinacidil (5-20 
µMo), a drug that shortens the action potential and in this way makes fibrillation easier to 
induce, to the perfusate and afterwards jiggle the electrodes of a 9 V battery on the 
ventricles. The addition of pinacidil greatly facilitated the induction of VF. 
 
 
5.8 Electrode configuration 
The electrodes that were used for nsPEF stimulation and defibrillation are made of 
aluminum and have dimensions of 1.5x3x0.1 cm. The electrodes were initially designed 
Figure 12: Electrode configuration and chamber. The electrodes are made of aluminum 




to be parallel. However, it was observed that the electrodes made limited contact with the 
heart, especially at the apex, and therefore the shock was mostly delivered at the base.  
The modified electrodes, shown in Figure 12, were designed to have an angle of 30O at 
the apex to better approximate the shape of the heart. The electrodes can also be moved 
laterally, to optimize contact 
 
5.9 Stimulation with nanosecond pulses 
During nsPEF stimulation, the heart was not paced with the ms stimulator but allowed to 
beat in sinus rhythm. The camera was set to record movies (1000 fps) for 3 to 5 seconds 
and between 1 and 2 seconds the shock was applied. The nsPEF detection system detects 
the frame in which the pulse was applied and assigns one of the pixels at the top corner 
with a higher value depending on the applied voltage. 
 
5.10 NsPEF stimulation with indium tin oxide (ITO) electrodes 
We also performed nsPEF stimulation with an alternative electrode configuration 
designed to record the shock-induced activity in the tissue next to the electrode.  Note 
that in the electrode configuration described in Figure 12, the nsPEF shock was delivered 
laterally and the electrical activity was recorded from the top. In this configuration, it is 
not known how the tissue closest to the electrode is affected and whether any damaged 
was being done by the shock. One of the means to study the adverse effect of shock on 
the cell structure is to study the baseline movement from the side on which the shock was 





To study the baseline shift due to the shock right under the electrode, we used ITO glass 
electrodes, Figure 13, instead of using regular electrodes. These electrodes consist of 
glass coated with indium tin oxide, and their special property is that they are transparent 
even though they have the excellent conductivity associated with metals.  A hole of 
diameter 7 mm was drilled in the center of the metal electrode and covered with the ITO 
glass electrode using a conductive seal. The electrical contact between metal and ITO-
coated glass was confirmed with a multi-meter before the start of the experiment. The 
electrodes were placed in the line of sight of the camera (rotated by 90° in the clockwise 
direction compared to the original configuration) and the electrical activity was recorded 
through the ITO electrode.  
 
Figure 13: Electrode with ITO glass electrode at the center. The glass 




5.11 Nanosecond pulse defibrillation 
Once sustained VF was initiated, the camera was set to record movies of 3 to5 second 
duration. After one second, the shock was applied. The movies were saved on a 
computer, while amplitude of the shock and the name of the movie were recorded 
manually in the lab journal. A quick evaluation of the recorded movie was done to 
determine whether the defibrillation was successful or not. If the shock was able to 
terminate the disorganized rhythm and normal SA activity was observed, we considered 
the defibrillation attempt successful. One minute after defibrillation, we recorded another 
movie of one second duration to confirm that the heart was still in sinus rhythm. If 
necessary, the heart was stimulated with a ms stimulator for few minutes to stabilize the 
heart before the next episode of VF was initiated. If the shock was unable to defibrillate 
the heart, the amplitude of the nanosecond pulse was increased by increasing the spark 
gap distance.  
 
5.12 Millisecond defibrillation 
A monophasic millisecond defibrillator that was built using 2 capacitors (10,000 μF), 
connected in parallel, which were charged through a charging resistor using a power 
supply up to the desired voltage. For defibrillation, the capacitor terminals are for 10 ms 
connected to plate electrodes (using solid state relays), so that the capacitors discharged 
through the heart.  We performed millisecond defibrillation in 2 hearts for 7 VF episodes. 
We started with 40 V for the first two times and the reduced the amplitude to 30, 





5.13 TTC staining 
In order to stain the heart, we switched from perfusing with Tyrode solution to perfusing 
with TTC dissolved in PBS 1%W/V. The heart was perfused with TTC for 15 minutes 
and preserved in formalin for sectioning. The hearts were then sliced every 2 mm from 
the apex to 2 mm above the suture.  
 
5.14 Signal and data analysis 
Raw movies acquired by the CCD camera (Little Joe, SciMeasure) were filtered with 
spatial and temporal averaging filters using custom-made software (QT/C++) to have a 
higher SNR.  Afterwards, movies were inverted (i.e. all pixel values were replaced by the 
maximum possible value minus the pixel value) to reverse the inversion of the electrical 
signals that takes place during optical mapping (for our filter choices). When we 
visualized the wave propagation, we linearly transformed every pixel value, so that the 
pixel values span the entire dynamic range of our system. We have shown data mean ± 
SD and used Student’s t-test when we compare them. 
 
5.15 Activation map 
An activation map illustrates the activation sequence of the heart, which enabled us to 
understand the dynamics of cardiac activation.  The algorithm that computes the 
activation map determines for every pixel when a user-defined excitation threshold is 
reached and considers the corresponding time as the local activation time. Once the 
activation times of all pixels have been determined, the times are associated with shades 




5.16 Amplitude Map 
An amplitude map shows the amplitude of the action potential for each pixel in the heart. 
The brighter pixels represent higher action potential amplitudes. The algorithm for 
determining the amplitude relies on finding the difference between the maximum and 






RESULTS AND DISCUSSION: NsPEF DEFIBRILLATION IN RABBIT HEART 
6.1 Stimulation of rabbit heart with nanosecond pulses 
We recorded 50 episodes of attempted stimulation in 5 rabbit hearts. In previous ablation 
experiments, we had shown that nsPEF amplitudes of approximately 10 kV/cm  
25 ms 0 ms 
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Figure 14: Activation map of sinus rhythm and nsPEF stimulated heart. Panel A shows 
the activation during to sinus rhythm. The black arrow shows the direction in which the 
sinus rhythm travels. Panel B shows the activation map after nsPEF stimulation. The 
arrows in Panel B shows that the activation starts from the two electrodes. The dark 
shades represent the earliest activation time while the lighter shades of gray shows the 
latest activation. The time for the activation to travel from the earliest activation to the 




can be used to ablate cardiac tissue. Since we wanted to avoid ablation, we decided to 
start with amplitudes far below the ablation amplitude values.  We found that shocks 
below 600V (over 3 cm) never succeeded in stimulating (6 episodes in 3 hearts), while 
shocks of 1.1 kV or above always succeeded (40 episodes in 6 hearts). In the range from 
750 V to 1 kV, stimulation attempts sometimes succeeded and sometimes failed, with the 
success rate increasing with shock amplitude. This stimulation range was quite broad 
because in the current pulse generator that was employed, the shock amplitudes were 
depended on the spark gap distance, and adjusting the gap for desired amplitude was 
always done by trial and error method. However, from these results, we can conclude that 
the stimulation threshold amplitude for rabbit heart lies between 750 to 1 kV over 3 cm, 
the distance between the two electrodes.   
 
The activation maps shown in Figure 14 illustrate the difference between sinus rhythm 
activation and shock-induced activation. While activation during sinus rhythm (Figure 
14A) starts in the lower left corner of the field of view and traverses the heart, shock-
induced activation (Figure. 14B) starts from both electrodes, which is expected because 
shock-induced membrane polarization should be largest near the electrodes.   In the five 
hearts studied, sinus rhythm always produced consistent activation patterns (even though 
these patterns would differ from heart to heart), while nsPEF activation always started 
from the electrodes. To assess whether nsPEF stimulation alters the electrical function of 
the heart, we compared action potential durations for regular activations originating at the 
sinus node with nsPEF-induced activations. In Figure 15, the action potential duration 




Out of the 50 episodes of successful stimulation, we included only those 15 episodes (5 
hearts) in the nsPEF effect determination that were performed using electrode 
configuration shown in Figure 12. 
 
6.2 NsPEF stimulation effect on action potential duration 
Pre–shock APD (210.87 ms, SD: 6.25 ms) and APD for shock-induced APD (209.45 ms, 
SD: 2.9 ms) are almost identical. We also studied the spatial distribution of APDs pre-
shock, shock induced and post shock (see Figure 16) and did not find any specific spatial 




Figure 15: Action potential duration (APD) analysis pre-shock, shock-induced 
and post-shock for a shock amplitude of 2 kV at 350 nanosecond duration. The 
red line shows the time at which the shock was delivered. The three analyzed 







6.3 NsPEF effect on diastolic interval 
The diastolic interval is the time between the end of an action potential and the start of 





Pre- shock Shock Post- shock 
Figure 16: Spatial distribution of action potential duration pre-shock, shock-
induced and post-shock. 
Figure 17: Diastolic interval between acute post-shock and post-shock. The arrival of 
the shock is marked by the red line. The shock induced an action potential following 






chambers of the heart get filled before the arrival of the next excitation. We calculated the 
diastolic interval pre-shock (i.e. during sinus rhythm), immediately post-shock and 
second post shock. Figure 17 shows the diastolic interval, immediately post shock, T2 and 
second post-shock T3. We evaluated 12 episodes of stimulation in 4 hearts. Average pre-
shock (T1) diastolic interval was 234.0 ms (SD 3.3 ms), whereas the average post-shock 
(T2) diastolic interval was 377.8 ms (SD 1.78 ms). The second post shock (T3) average 
was 234.3 ms (SD  2.6 ms).  In other words, the diastolic interval directly post shock was 
always 40 to 50% (p < 0.05) longer than the pre-shock and second post-shock interval. 
The diastolic interval returned to the pre-shock range after the first post shock interval, 
and the change from pre-shock to second post-shock were virtually identical.   
 
From the data, we can conclude that nsPEF stimulation does have a transient effect on the 
electrical dynamics of the heart, but this effect appears to pass within a single action 
potential (about 0.5 seconds).   
 
 6.4 Spatial uniformity of action potentials during nsPEF stimulation  
To determine whether the shock induced action potentials remain uniform across the 
heart, we analyzed the action potential amplitude and duration from the center of one 
electrode to the other electrode (Figure 18A) at every 2 to 3 millimeters (roughly an 
estimated 10 to 11 positions) in 4 hearts that were stimulated with the electrode 
configuration shown in Figure 12.  Figure 18A shows the 10 positions at which we 




at which the shock was delivered (marked by a red line) and the action potentials 
recorded from positions marked 1 and 2 in Panel A. The APD (Figure 18B) at position 
marked 1 was 234 ms while the APD (Figure 18B) that at position marked 2 was 238 ms.  






Figure 18: Action potentials at different distances from the electrodes for nsPEF 
stimulation of a rabbit heart. Panel A shows the 10 recording sites from the surface of the 
heart. Panel B and Panel C are the action potentials recorded from the 2 location marked 1 




duration did not significantly vary over the ten positions (p < 0.5). An important 
implication is that even for the myocardium closest to the electrode, the APD has 
remained electrically unaffected by the shock.  
 
6.5 NsPEF stimulation indium tin oxide  
It is known that defibrillation shocks of sufficient amplitude can result in the 
electroporation of plasma membrane which in turn can result in serious damage to the 
tissue[57], [58]. The injury and cell death are a result of the leakage of intracellular 
components through the compromised membrane, as well the entry of solutes from 
extracellular medium.  Since pores in the membrane also allow ions to pass, 
electroporation is associated with an upward shift in the transmembrane potential 
(depolarization).  To look for this telltale sign of electroporation, we looked for upward 
baseline movements of the action potential recordings following the shock.  Out of 35 
episodes of stimulation using the ITO electrode in one heart, 25 showed no sign of 
baseline shift.  Nine further recordings showed an apparent baseline shift, but only in a 
narrow ring along the edge for the ITO window.  The fact that in the rest of the 
preparation, no baseline shift could be detected strongly suggests that the shift is really 
motion artefact; the illumination changes dramatically around the edge of the ITO 
window, and the shock may be associated with small motions of the heart.  In the 
remaining heart the recording we could not conclusively determine whether a baseline 
shift occurred. These data suggests that the stimulation with 1.5kV nanosecond shock did 






6.6 Reentrant Arrhythmias 
Once we were able to stimulate the hearts with nsPEF, we induced reentrant arrhythmias 
as described in section 3.7. We considered both tachycardia (Figure 19A) and ventricular 
fibrillation (Figure 19B), because they are closely related (tachycardia indicates the 
 
Figure 19: Recordings during ventricular fibrillation. Panel A shows a regular 
electrical activity but at very high frequency (2 to 3 time faster than normal heart). 
Panel B shows the ventricular fibrillation. Both types of arrhythmias are considered 






presence of one reentrant wave, while ventricular fibrillation consists of several such 
waves) and are typically regarded as equivalent in defibrillation studies. We successfully 
induced 7 episodes of tachycardia and 18 episode of VF in 10 rabbit hearts.   Figure 19 
shows the electrical activity recordings during tachycardia and ventricular fibrillation. In 
case of tachycardia, there is only one reentrant wave, and the frequency of activation is 3 
to 4 times faster than normal sinus rhythm as shows in Figure 19A. In case of VF, there 
are multiple reentrant waves and the electrical activity is also highly disorganized as 
shown in Figure 19B and any fibrillation which sustains itself for more than 30 seconds 
after the induction is considered as sustained ventricular fibrillation. 
 
6.7 NsPEF defibrillation 
The Figure 20 shows a typical episode of VF followed by a shock of amplitude 2.4 kV 
marked by red line, and normal sinus rhythm action potential recording. We performed 
ms 
au 2.4 kV, 350 ns, single shock 
Figure 20: Ventricular fibrillation recording followed by nsPEF defibrillation and 




33 defibrillation attempts of sustained ventricular fibrillation with nsPEF, with shock 
amplitudes varying from 2.3 kV to 3 kV.  Out of the 33 defibrillation attempts in 14 
hearts, 25 attempts were successful (75%).   
 
6.8 Defibrillation threshold  
Shocks below 2.3 kV never succeeded in defibrillating. The success rate of nsPEF 
defibrillation with 2.3 kV was 37 % (3 successes out of 8 trials) while for 2.4 kV, it was 
62.5 % (5/8). The success rate for amplitude 2.6 kV was 83% (5/6), and for amplitudes 
above 2.6 kV, we had 100%  defibrillation success (11/11).  Between 2.3 kV and 2.4 kV 
defibrillation amplitudes, we had 50% (8/16) successful defibrillation.  The defibrillation 
threshold is usually defined as shock strength that defibrillates the heart 50% of the 
time[59], [60]; according to this definition, the threshold for nsPEF defibrillation in our 
experiments lies between 2.3 and 2.4 kV. 
6.9 Defibrillation patterns 
  
Figure 21: nsPEF defibrillation patterns. Panel A shows fibrillation and shock-
induced action potential and then no activity for few seconds. Panel B shows 










We observed 3 different patterns of successful nsPEF defibrillation.   In the first pattern, 
we observed that following the application of the shock, the heart returns to sinus rhythm 
with a slightly longer diastolic interval immediately after the shock (Figure 20). The 
second pattern that we observed was that following shock, the heart shows no sign of 
electrical activity for an extended period of time (2 to 3 seconds) and then returns to 
normal sinus rhythm (Figure 21A). The movies recorded following such a pattern show 
that the action potential amplitude and duration were same as before the induction of 
ventricular fibrillation.  
 
In the third pattern, we observed following the application of shock, the electrical activity 
halts for about 0.5 second to 1 second and then the heart returns to the sinus rhythm with 
no significant changes to the amplitude and diastolic interval (Figure 21B).    
 
There were 25 episodes of successful defibrillation with nsPEF. Out of these episodes, 17 
exhibited pattern 1, while patterns 2 and 3 exhibited 4 episodes each. As all these patterns 
were observed for both low amplitudes (2.3 kV) and higher amplitudes (3kV), we cannot 









6.10 NsPEF effect on diastolic interval 
We also analyzed the diastolic intervals following defibrillation shock, using a similar 
methodology as in Section 4.3 for stimulation. One difference is that the heart is initially 
fibrillating, so we cannot evaluate action potential durations or diastolic intervals before 
the shock.  
 
The diastolic interval immediately after the shock (T1) was always longer than the normal 
diastolic interval (T2, Figure 22). The average first post shock diastolic interval was 425 
ms (SD 138 ms) while the average second post shock diastolic interval was 283 ms (SD 
112 ms) which was 50 % (p < 0.05) longer than the second post shock diastolic interval. 
The subsequent diastolic intervals were very close to the second post shock intervals.  
This analysis was performed on the 17 episodes of nsPEF defibrillation pattern 1. The 
other episodes were not included as they either did not have the first post-shock or second 
post shock diastolic intervals.   
  
  
Figure 22: Diastolic interval patterns in nsPEF ventricular defibrillation.  The first 











In summary, defibrillation shocks, like the weaker stimulation shocks, have only a 
transient effect on the diastolic interval (lasting one heart beat). 
 
6.11 No baseline shift following nsPEF defibrillation 
 
As in Section 4.5 for stimulation, we looked for baseline movements of the action 
potential recordings following nsPEF defibrillation shocks. One difficulty is that since 
baseline is not reached during ventricular fibrillation, we cannot establish a pre-shock 
baseline.  It is, however, typical that shifts in baseline fade out over the course of seconds 
(as the heart recovers from electroporation), so that a downward drift of the baseline is 
observed (Figure 23). We looked for such a downward drift in our 25 episodes of 










6.12 Tetrazolium Chloride (TTC) stain  
TTC staining is a technique that can be 
used to differentiate the viable tissue 
from non-viable ones. The colorless TTC 
enzymatically turns to a red formazan 
product in metabolically active cells, 
while dead tissue remains unstained. In 
our experiments, if there was any tissue 
damage due to the nanosecond shock, it 
should occur rather at the electrodes than 
towards the center.  We performed TTC 
staining on one heart (see Figure 24). In 
this experiment, we had applied a single 
2 kV shock, a single 2.3 kV shock, one 
double 2.3kV shock, one double 2.6 kV shock, and three single 2.4 kV shocks.  In this 
heart, TTC staining did not reveal any dead tissue near at the electrodes. However, we did 
observe some areas of the septum which remained unstained, but we believe that this was 
not caused by the shock but by problems associated with the perfusion of the tissue. 
 
6.13 Millisecond defibrillation 
The standard way of defibrillation is to deliver a millisecond shock (Figure 25) directly to 
the heart.  We used the standard defibrillation as a control against the nanosecond pulse 
defibrillation. We performed millisecond defibrillation on 2 animal hearts for 7 VF 
Electrodes 
Figure 24:  TTC stained rabbit heart. 
Cross section of the heart stained with 
TTC. The 2 white lines show the position 




episodes. The first two 40 V (Figure 25) shocks successfully defibrillated (Figure 26) the 
heart. In order to determine the threshold of millisecond defibrillation, we reduced the 
amplitude to 30 V.  
 
The 30 V shock failed to defibrillate the heart and therefore the shock amplitude was 
increased to 35 V which successfully defibrillated the heart. The 35 V shock defibrillated 
the heart 50% of the time while the 40 V shock had higher success rate of 75%. This data 
suggests that the threshold for millisecond defibrillation is approximately 35 V over 3 cm 
(distance between electrodes), but more experiments are necessary to establish a precise 
value.  A sample action potential recording during a millisecond defibrillation is shown in 
Figure 26. The time at which the pulse is delivered is marked by the red line (Figure 26).  





6.14 Energy required for nsPEF and ms defibrillation 
 Since we are interested in comparing the energies required for millisecond and nsPEF 
defibrillation, we measured current flowing through the circuit during defibrillation is 
recorded using a Pearson probe. The energy required to defibrillate the heart during the 
five episodes of defibrillation is then calculated using the equation: 
 





   (9) 
It was found that the energy required is around 530 ± 80 m J in 5 episodes of ms 
defibrillation which is consistent with the literature values. 
Figure 26:  Action potential recording during ms defibrillation. The time at which the 
shock is delivered is marked by a red line. The shock induces an action potential after 




Since energy was an important reason for the development of nsPEF defibrillation. The 





𝐶𝑈2,   𝑐 = 21.2 𝑛𝐹𝐹 
 
   (10) 
 
 
In comparison to the ms pulse, where energy deposited at the threshold is 530 ± 80 mJ 
(n=5), the ns pulses reduce the deposited energy by a factor of approximately 8. 
 
6.15 Conclusion 
We showed that nsPEF can be successfully used to stimulate and defibrillate rabbit 
hearts. The nsPEF amplitude required to stimulate rabbit hearts lie in the range of 0.75 to 
1kV for a distance of 3 cm. The action potential recording also showed that the 
application of nsPEF did not affect the heart electrophysiologically in terms of action 
potential duration and diastolic intervals. The myocardial damaged assessed by TTC 
staining did not see tissue damage, especially close to the electrodes where the effect if 
any, should have been more visible. We also showed that the energy required to 















EFFICACY OF INJECTABLE THERAPEUTIC AGENT IN PROMOTING 














INTRODUCTION: TA-TREATED RAT HEARTS 
1 out of 4 deaths in a year, that is 600,000 in the US, is caused by heart disease, and half 
of these deaths are attributed to coronary heart disease[61]. The most serious form of 
coronary heart disease is myocardial infarction (MI). It occurs when a coronary artery is 
so severely blocked that there is a dramatic reduction or complete disruption of blood 
supply, causing damage or death to the 
territory of the myocardium (heart 
muscle) that was supplied by the blocked 
coronary vessel (see Figure 27)[62], [63] . 
The coronary vessel gets blocked due to 
plaque buildup called atherosclerosis 
and/or by a clot (e.g. of coagulated blood) 
that obstructs the flow of blood in the 
vessel[62] (Figure 27).  
 
7.1 Pathogenesis of myocardial infarction 
Following MI, affected tissue undergoes an initial inflammatory phase, to up-regulation 
of matrix metalloproteinases (MMPs) that progressively degrade the extracellular matrix 
(ECM), causing the realignment of myocyte bundles and individual myocytes, which 
leads to infarct expansion and heart wall thinning, and finally to a collagen scar being 
deposited to prevent ruptures and deformations of the myocardium[64]. The myocardium 
is unable to restore its original cellular and extracellular matrix composition, that results 




in the left ventricular (LV) remodeling. LV remodeling is the resizing of ventricular size, 
shape and function due to mechanical, hormonal and genetic factor[65], [66]. The 
remodeling can happen during normal growth to adapt to physiological changes or can be 
pathological due to cardiac vale disease, cardiomyopathy or  myocardial infarction[65], 
[66]. This is seen to progress to cardiac dysfunction and eventual heart failure[64]. Heart 
failure typically necessitates a heart transplant or LV assist device, the only currently 
available treatments. Thus, there is a need to develop new and effective treatment that 
could regenerate infarcted tissue and prevent the development of heart failure.  
 
Recently, a number of approaches using regenerative medicine have gained significant 
attention in treating heart disease. Some of the approaches use cellular therapies and gene 
therapies while there are also developments using extracellular matrix derived 
biomaterials with some degree of success. Bone marrow cell based therapies are used in 
trials to stop the progression of ischemic cardiomyopathy and congestive heart failure but 
with have limited success, however cardiac progenitor cells were found to be more 
promising in regenerating myocardial tissue following infarction[67], [68]. Cell 
therapeutics using autologous cells in regenerative cardiac treatment have donor-to-donor 
variability which makes treatment more complicated.     
 
In many studies, it was observed that the injection of cells at the site of injury have 
further complicated due to the difficulties in retention, integration and survival of the 




led to the use of biomaterial scaffolds such as ECM and growth factors for delivering 
cells to the infarcted region[69].    
 
Biomaterials like Matrigel derived from basement membrane rich matrices and pig 
muscle-derived  matrices have been found to be promising in regenerating infarcted and 
ischemic tissues by promoting angiogenesis and preventing remodeling of LV in rats and 
porcine models[69], but murine sarcoma-derived Matrigel is found to be problematic for 
human interventions, and porcine matrices are found to under-perform compared to 
human-derived matrices[70]. There are also risks involved in using animal tissue in 
humans like immune rejection due to the presence of cell particles, DNA and other 
remains of ECM from animal tissue.  
 
In this study, we tested a newly developed injectable therapeutic agent (TA).  Due to non-
disclosure agreements (NDA) signed, we are not able to describe the motivation of the 
approach or the composition of the TA.  
 
7.2 Development of experimental model 
In rats as in humans, sufficiently large infarctions typically develop over time into   heart 
failure[71].This made rats a preferred infarct model, and we chose it for this study as 
well. 
It is known from the literature that the myocardial infarction models in small rodents are 




involving survival surgery that our lab embarked on. Keeping this in mind, we initially 
designed the study into 2 cohorts, the first to test and validate our surgical approach and 
the second for myocardial treatment with TA. In the first cohort, the goal was to master 
the infarction model animal surgery with at least 50 % survival. As we started with the 
surgeries, this proved to be an ambitious goal. The challenges faced in the first cohort 
started with intubation to sedate the animal.  The small size of the larynx made it hard to 
visualize the tracheal opening while inserting the catheter, and the intubation catheter can 
easily become inserted into the neighboring esophagus by accident.  The procedure was 
made further complicated since multiple unsuccessful intubation attempts caused 
laryngospasm glottic and local tissue trauma.  Also, if the rat was not successfully 
intubated in the first few attempts, the animal would regain glottic reflexes, which made 
subsequent intubation attempts even more difficult. Our surgical approach further 
required an intravenous line, which was difficult to place in the small veins of our rats.  It 
was also challenging to ligate a branch of the coronary artery to create myocardial 
infarction without causing substantial blood loss during or after the surgery (due to the 
small size of the rat heart). Due to these difficulties and the low success rate, we decided 
to consult with Dr. Salloum from Viginia Commonwealth University, who is an expert in 
small rodent surgery and has performed more than 3000 myocardial infarct surgeries in 
small animals successfully. Following the visit to Dr. Salloum’s laboratory, the surgery 
procedure was modified (see chapter 6) with the addition of another cohort to the study 
thus increase the study groups to three.  In the second cohort, we established the new 






METHODS: TA-TREATED RAT HEARTS 
8.1 Myocardial infarction model 
All animal experiments in this study were conducted in accordance with an approved Old 
Dominion University Institutional Animal Care and Use Committee protocol. The studies 
were conducted in an AAALAC accredited facility. The animal surgeries are divided into 
three cohorts. The goal of cohort 1 study was to establish the surgical procedure. This 
procedure was performed on 9 Sprague Dawley male rats whose weight was in the range 
of 450 gms to 500 gms.   The animals were anesthetized, shaved, weighed, and 
echocardiography performed 2 days prior to the surgery. On the day of surgery, each 
animal was anesthetized with 3% isofluorane, injected with ketamine (50 mg/ml, 0.68 
ml) and xylaxine and intubation was performed with a 16 G catheter through the mouth 
into the trachea.  The catheter was connected to a ventilator and the rat was ventilated 
with isofluorane at 2.5% and 400 ml/min oxygen.  The stroke volume was set at 3.4 ml 
and 75 strokes per minute. Just before surgery, amiodarone (an anti-arrhythmic) was 
injected to decrease the cardiac sensitivity. The animal was placed on a heating pad and 
prepped by alternate swabbing with betadine and 70% isopropyl alcohol (IPA) (3 times 
each) and then draped. Ophthalmic ointment was applied. Once intubated, we performed 
a left thoracotomy (2-3 cm) in the third or fourth intercostal space to access the heart. The 
heart was pushed up with the side of the left anterior descendant (LAD) branch of the 
coronary vessel pointing towards the surface to access the heart by placing sterile cotton 
gauze soaked in the saline underneath the heart and by using cotton swabs. Any blood in 




place, the distal branch of the LAD was located and a stitch was made with 5-0 silk to 
ligate the vessel. It was also made sure that the needle did not pierce too deep to penetrate 
the chambers. The retractors were released and the opening was covered for 30 minutes 
with sterile gauze soaked with saline to prevent the tissue from drying. The 30 minute 
window mimics the conditions in human assuming that it takes about 30 minutes for the 
patient to reach the hospital following the onset of symptoms of heart disease.  At the end 
of 30 minutes, the retractor was placed again and saline was used for control injection, 
0.075 ml divided between 4 sites around the ligated vessel was injected. The needle was 
bent at the tip so as to make sure that the needle does not pierce all through the 
myocardium into the ventricles. During suturing, the isofluorane was reduced, from 2.5 to 
1.5% while the muscle was sutured and to 1.0% while the skin was sutured. When 
suturing was complete, the ventilator was disconnected.  When the animal showed the 
first signs of waking, facial twitches and tail movement, the intubation tube was removed 
and the animal moved to a clean housing cage on the heating pad. The pleural cavity was 
closed, using 4-0 vicryl for all 3 layers: four interrupted stitches were used to close the 
ribs, 5 running stitches to close the muscle layer and 9 interrupted stitches to close the 
skin. Phenylephrine (anti-hypotensive) was injected whenever there was a drop in blood 
pressure. Lidociane (a vaso-antispasmatic) was given continuously via an IV drip to 
prevent vascular spasms during the surgery. Rimadyl (carpofen) tablets were added to the 





In the second cohort, 8 more animal surgeries were performed on the basis of the 
procedure observed in Dr. Salloum's laboratory at Virginia Commonwealth University, 
VA. Dr. Salloum has performed more than 3000 small rodents including mice and rats 
survival surgeries. Dr. Salloum did not use any drugs to other than isoflurane (to 
anesthetize the animal). His intubation technique relied on illumination of the larynx 
through the tissue of the throat, thus avoiding that the intubation tube would cast a 
shadow on the vocal fold. Dr. Salloum also pointed out what exactly we needed to look at 
in the view down the mouse's throat, and showed us how with experience, the intubation 
can be done reliably in seconds. The entire infarction surgery took only about 3-5 
minutes, as opposed to the 1-2 hours our more complex procedure had taken. 
 
As before, the animals were anesthetized, shaved, weighed, and echocardiography was 
performed 2 days prior to the surgery. In these set of experiments, the animals were 
anesthetized and intubation with a 14 G catheter was performed while the animal was laid 
in supine position on a intubation stand and the larynx illuminated from outside. 
Amiodarone and phenylephrine were no longer used during the surgery. Rimadyl 
(carpofen) tablets were added to the cage every day for the next 3 days whenever the 
animal survived the surgery.  
 
In cohort three, we used TA to test the efficacy in treating myocardial infarction in rat 
hearts.  Sixteen Sprague Dawley male rats (~500 g) were purchased from Harlan 
Laboratories (Indianapolis, IN).  Animals were allowed a 48-hour acclimatization period 




anesthesia was initiated with 3-4% isoflurane inhalation and an intramuscular injection of 
acepromazine at 1 mg/kg. Intubation was performed with a 16G intravenous catheter, and 
animals were ventilated with a volume-controlled ventilator at 8-10 ml/kg tidal volume at 
70 breaths per minute. 2-3% isoflurane was used to maintain anesthesia. A heating pad 
placed underneath the animal was used to support body temperature throughout the 
procedure. Animals received a prophylactic 14 day antibiotic course of trimethroprim 
sulfate at 0.5 mg/kg daily, and sterile technique was utilized to prevent infection.  
 
Electrocardiogram (ECG) leads were placed on the right and left side of the animal's 
thorax and monitoring of the ECG was performed throughout the procedure and recorded 
for analysis. The heart was surgically exposed with a left thoracotomy at the fifth 
intercostal space.  Pericardial removal exposed the left anterior descending (LAD) 
coronary artery. LAD coronary artery occlusion was performed with a 5.0 silk suture to 
induce ischemia in the distal regions of the left ventricular myocardium. Observation of 
blanching of the myocardium was used to confirm induction of ischemia, along with 
ECG monitoring. Treatment with TA or sham (saline) injections was initiated thirty 
minutes after the induction of ischemia, in order to ensure myocardium death in the 
ischemic region prior to injection. During this time thoracic cavity was left exposed, but 
covered with moist gauze to minimize dehydration and infection. Following injections, 
the thoracic cavity was closed with 4-0 vicryl suture. The lungs were momentarily fully 
inflated to expel any air trapped in the thoracic cavity prior to sealing the cavity to 




closed with 4-0 vicryl suture in an interrupted pattern.  Pain was controlled with 
carprofen and buprenorphine for at least 48 hours until no longer needed. 
 
8.2 Echocardiography 
Echocardiography was performed 2 days prior to the surgery and twice post-surgery, at 4 
weeks and 8 weeks, on all control and TA-treated rats using a Vevo-770 (VisualSonics) 
with a 13-23 MHz non-linear array transducer. Each rat was anesthetized with 1.5–2.0% 
isoflurane by mask, the chest was shaved, the animal was laid in the supine position on a 
warming pad (Sunbeam). Two dimensional M-mode and B-mode data were recorded in 
parasternal long and short axis. All data were analyzed offline with ultrasound machine 
software at the end of the study. All echocardiogram measurements were performed 
using the same equipment and by the same examiner.  The examiner was not aware 
whether the rat under examination was TA-treated. 
 
8.3 Treatment of ischemic myocardium 
TA was warmed to room temperature prior to injection into the myocardium. Thirty 
minutes post-ligation, three injection sites in the ischemic myocardium were chosen 
based on the location of blanching, indicating the ischemic region. Each treatment site 
received 25 μL of TA for a total of 75 μL. No backflow of TA was observed. A sham 






8.4 TA remains at the site of injection 
An important question is whether the TA that we injected remains at the injection site or 
flows back out of the tissue once the needle is remove or would flow back due to the 
muscle resistance. This was important to know because, the whole study was 
hypothesized on the basis that TA remains at the site of inject and plays the major role 
recruiting the cardiac stem cells and promoting angiogenesis at that site of injury.  We 
confirmed that the TA remains at the injection site, but because of an NDA, we are not 
able to provide the details here.   
 
8.5 Optical Mapping  
8.5.1 Heart harvest 
Eight weeks after the initial surgery, hearts were extracted and their electrical activity 
was analyzed with optical mapping35.  Each animal was brought to a surgical plane of 
anesthesia with 3-5% isoflurane and injected with 1 IU/g heparin.  Bilateral thoracotomy 
was performed to expose the heart. The heart was then excised and immersed in ice-cold 
Tyrode solution (128.2 mM NaCl, 1.3 mM CaCl2 (2H2O), 4.7 mM KCl, 1.05 mM MgCl2 
(6H2O), 1.19 mM NaH2PO4, 20 mM NaHCO3, 11.1 mM D-Glucose in deionized water, 
pH=7.35±0.05).  The aorta was cannulated and the coronary system flushed with ice-cold 
Tyrode solution to reduce metabolic rate.  The cannulated heart was then transferred to 






8.5.2 Experimental setup 
Our experimental setup can be divided into the life support system and the optical 
mapping setup.  
 
8.5.2.1 Life support system 
Our life support system keeps the heart alive outside the body for up to 12 hours. It has a 
chamber that contains the Langendorff-perfused heart; the heart is also super-perfused 
with Tyrode solution so as to maintain ambient temperature at 37+/-1 degree Celsius. The 
Tyrode solution is aerated with 95% O2. Since the oxygen concentration affects the pH, 
which needs to be maintained in a narrow range of 7.35 to 7.45. The pH and temperature 
stabilized solution is then pumped at a rate to maintain a pressure of 50 to 60 mmHg in 
the heart. We also use an excitation-contraction decoupler, either   2, 3-butanedione 
monoxime (BDM) or blebbistatin, to remove any motion artifact. 
 
8.5.2.2 Optical Mapping System 
The optical mapping system (Figure 28) consists of laser, mirrors, diffusers, filters and a 
CCD camera. The type of the laser used for illuminating the heart depends on the dye that 
is used for the experiment and in this project we plan to use voltage sensitive dye called 
Di-4-ANBDBQBS. DI-4-ANBDQBS stock solution was made by dissolving 10 mg of 
dye in 1.2 ml of pure ethanol, made fresh for each experiment. 30 μL of the stock DI-4-
ANBDQBS solution was diluted with 15 mL of Tyrode's solution and injected as a bolus. 
Since Di-4-ANBDBQBS has an excitation wavelength of 671 nm, we use a red laser to 




directed through a 5-degree conical diffusor and then through a dichroic mirror λcrit = 690 
nm) onto the heart to achieve uniform illumination.  
 
8.6 Millisecond pacing of heart 
The heart is stimulated with millisecond pulses at different points on the viable 
myocardium far from the ligation, very close to the ligation and in between the ligated 
tissue and the normal tissue and movies are recorded.  
 
When the heart was excised at the end of 8 weeks, it was typically observed that the heart 
adhered to the ribcage at the apex. This is a normal phenomenon observed in coronary 
artery ligation surgery. The adhering tissue was carefully removed, while making sure 
that there is no damage to the myocardium. While complete removal was generally not 
possible, we pierced the tissue whenever we stimulated the heart from the apex. 
Figure 28: Typical optical mapping system consisting of 





At the end of optical mapping, the heart is perfused with TTC (2,3,5-triphenyl 
tetrazolium chloride) solution, 1 gm TTC dissolved in 100 ml of non-buffered saline. 
Infarct size can be assessed by using the staining agent TTC[75]. TTC stains the viable 
tissue to red while the infarcted tissue remains unstained[76]. This solution is recirculated 





























RESULTS AND DISCUSSION: TA-TREATED RAT HEARTS 
9.1 Surgery performance 
The objective of cohort I study was to develop infarct model to the point that we are 
confident that our surgical procedures are appropriate. In the first set of surgeries in 
cohort 1, 9 animal surgeries were performed and only 1 rat survived.  One of the major 
difficulties that we faced during this study was the intubation. The vocal cleft in rats is 
very small, and the intubation catheter easily slips into the adjacent esophagus.  Repeated 
unsuccessful attempts led to complications, such as laryngospasm glottic and local tissue 
trauma.  Also, if the rat was not successfully intubated in the first few attempts, the 
animal would regain glottic reflexes, which made subsequent intubation attempts even 
more difficult.  We tried intubation after tracheotomy, but even this more invasive 
approach yielded only modest improvements and probably reduced the chances for long-
term survival. Another major difficulty was locating the LAD branch to ligate. A small 
opening to access the heart, about 2-3 of centimeters, and the motion of the heart while 
contracting add more difficulty in locating the branch of the LAD.  
 
Placing an IV catheter to administer drugs was also difficult.  Even the jugular vein (one 
of the biggest available veins) took several attempts and substantial time to cannulate, 





Only 1 out of the first 9 rats survived the surgery, and that survivor also died soon after 
the surgery. Overall, our procedure became lengthy, required improvisation, and had a 
low success rate.   
 
Following the visit to Dr. Salloum’s lab and the improvements in the surgery as described 
in the methods section, the surgery success rate in the cohort II study increased from 10% 
to 50%. The entire infarction surgery took only about 3-5 minutes, as opposed to the 1-2 
hours previously. The surgery success rate in cohort III further increased to 70%.  
  
9.2 Cohort III rat study 
The objective of cohort III study was to collect preliminary data showing the efficacy of 
TA treated heart. In the cohort III study, we performed 14 surgeries, and 10 rats survived 
the surgery. From these 10 rats, 8 (4 control and 4 TA treated) survived for full 8 weeks 
while 1 was euthanized after 2 week and one after 4 weeks. 
 
  
9.3 Control heart echocardiogram data 
Reduced ejection fraction is one of the important parameters that causes mortality for 
those with  myocardial infarction[77] . Also in case of animal models, it has been widely 
accepted that myocardial infarction in rats hearts decreases the ejection fraction[78] as is 
the case in heart failures in humans[79]. Another parameter that is widely seen in 





Decreased EF and increased heart rate are commonly used indicators for the presence of 
myocardial infarction.  By evaluating these 2 parameters, we can determine the cardiac 
























Figure 29: Ejection fraction in control hearts at pre-surgery, post-surgery 
4weeks, and post-surgery 8 weeks. 
Figure 30: Heart rate in control hearts at pre-surgery, post-surgery 4weeks, and 





The typical ejection fraction in rats is about 72% to 75% while the typical range of heart 
rate in a normal rat is about 250 bpm.  As the myocardial infarction progresses, the ability 
of the heart to contract decreases, thus reducing the ejection fraction. As the ejection 
fraction decreases, the heart tries to keep the same amount of blood being pumped out of 
the heart by increasing the heart rate. In cohort II, we performed myocardial infarction 
surgeries on 6 rats for the control group and all 6 survived the surgery, however, one died 








Figure 31: ECG recording in a control heart. Panel A shows the ECG just before ligating 
one of the branches of the LAD. The QRS complex looks regular and the heart rate is 
about 300 bpm. In Panel B at the end of 30 minutes of ligation. The QRS complex is 





The ejection fraction decreased in all the rats (see Figure 29) while heart rate increased as 
shown in Figure 30. The average ejection fraction pre-surgery was 73.1 % (SD: 3.31%) 
which dropped to 69.6% (SD: 5.02%, p < 0.3 ) after 4 weeks of surgery. At the end of 8 
weeks the ejection fraction was 64.5% (SD: 3.32%,). The average drop in ejection 
fraction in control heart was 8% (p < 0.05), at the end of 8 weeks. In case of heart rate 
(Figure 30), the average pre-surgery heart rate in control rats was 257 bpm (SD: 25.4 
bpm) which increased 330 bpm (SD: 12.6 bpm, p < 0.05) at the end of 4 weeks. At the 
end of 8 weeks the average heart rate rose up-to 345 bpm (45 bpm,). Thus the change in 
heart from a pre-surgery stage to 8 week post-surgery was 30% (88 bpm p < 0.05).  
 
During the process of surgery, we monitored the electrocardiogram to assess the 
condition of the heart in terms heart rate and shape of the QRS. Figure 31 shows a 
representative picture of an ECG recording during the surgery. Figure 31A shows the 
ECG recording in a control heart just before the ligation and Figure 31B, shows the ECG 
recording at the end of 30 minutes of infarction in the same heart. The rat in study had an 
initial 300 bpm heart rate at the start of the surgery, which increased to 500 bpm at the 
end of the surgery. This animal died at the end of the surgery. Also the QRS complex 
have approximate 50 % decrease in amplitude while the heart rate increased by 60%, (see 
Figure 31B). This change in QRS complex amplitude was observed in all hearts however 
the variation in the amplitude changed from heart to heart.  Also, the ST segment of the 
ECG shows elevation compared to pre-ligation recording. The elevated ST segment 




infarction[81], however, the animal in this study did not survive the surgery. The ECG 
recordings were not used for quantitative analysis. 
 
9.4 Electrical activity in control hearts  
To determine which part of the cardiac surface has impaired electrical activity, we 
stimulated the tissue at multiple locations around the ligation and monitored the response 
of the heart using optical mapping. Figure 32 shows a representative figure of the  
electrical activity in control hearts. In Figure 32A, the stimulation site and the ligation 
site are marked by black dot and a circle respectively. Figure 32B shows the activation 
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Figure 32: Optical mapping of control heart. Panel A shows the fluorescence image of 
control heart. Panel B is the amplitude map of Panel A. Panel C shows the activation 
map in the same heart, when the heart is stimulated in the infarct zone. Panel D shows 




map, where the darker shades represent the earliest activation times. Figure 32C shows 
the amplitude map of the heart. The heart was stimulated from close to the ligation at a 
frequency of 3 Hz, however, the action potential recording shows the presence of one 
activation. This activation according to the activation map starts from the base of the 
heart suggesting sinus rhythm. The heart failed to respond to the ms stimulation when it 
was paced close to the ligated region, giving a strong evidence for the presence of 
infarction.  
 
9.5 TA treated heart echocardiogram data 
As discussed in Section 7.3, the ejection fraction and heart rate are used to assess the 
efficacy of TA in reducing the severity of the infarct. If TA actually regenerates the 
infarcted heart tissue, then the ejection fraction and heart rate should be closer to normal 
heart echocardiogram than the ejection fraction of control hearts.  The 4-week and 8-































Figure 33: Ejection fraction in TA-treated hearts at pre-surgery, post-surgery 4weeks, 




hearts, the average ejection fraction (Figure 33) at pre-surgery was 72.8% (SD:2.4%) 
which decreased by less than 2%  (p < 0.07) to 69.65 % (SD: 1.78%) and remained so 
until 8 weeks.  
 
In the TA-treated hearts, the average pre-surgery heart rate (Figure 34) was 262 bpm 
(SD:20 bpm) which increased to 314 bpm (p < 0.05) at the end of 4 weeks and then 
slightly increased to 323 bpm (SD: 21 bpm) at the end of 8 weeks. 
 
9.6 Comparison of control and TA-treated hearts 
In control hearts the ejection fraction dropped from the pre-surgery to 4 weeks to 8weeks 
while the heart rate increased as the time passed from pre-surgery to 8weeks. In the TA 





























Figure 34: Heart rate of TA treated hearts at pre-surgery, post-surgery 4weeks and 




after that it remained the same while the heart rate also increased during the first 4 weeks 
after which it stabilized.  
 
The average drop in the ejection fraction in TA treated heart was about 3% compared to 
9.5 % (p < 0.02) in control hearts. Also the heart rate in control heart at end of 8 week 
was 346 bpm (SD 45 bpm), a change of 35% where as in TA treated heart, the average 
heart rate was 323 bpm (SD: 21 bpm,), a change of 25 % (p < 0.4).    These data also 
suggest that TA may substantially reduce infarct development, but experiments with 
larger cohorts are needed to validate this finding.  
 
9.7 Improved electrical activity in TA injected hearts     
Optical mapping revealed that the surviving tissue in TA treated hearts had normal 
electrical activity, in particularly no slowing of conduction or changes in action potential 
duration relative to normal healthy control hearts. Figure 35A shows a photograph of a 
rat heart in our optical mapping setup.  Figure 35B shows a representative activation map 
for a saline-treated heart with a large infarct.  The smooth transition from black to white, 
with approximately equal widths for the different shades of gray, indicates that the 




A rough estimate of the propagation velocity can be obtained by dividing the distance 
between the stimulation site and the point of latest activation (~12 mm) by the time of the 




Figure 35. Electrical activity of ITA-treated rat hearts.  A photograph of saline-treated 
heart is shown in the optical mapping setup for reference (A).  The stimulation electrode 
can be seen as a black line, a red “+” has been placed at its tip to mark the stimulation 
site. The bright areas in the left part of the heart are reflections from a thin layer of 
pericardium that attached to the epicardium. Representative activation map of saline-
treated heart are shown in (B) (from the same heart as in Panel A). Arrows indicate the 
direction in which activation propagates from stimulation site.  Red circle marks the 
ligation site; bright red area the infarct, dark red is not infarcted by the attached 
pericardium precluded computation of activation time. Representative activation map of 
ITA-treated heart are shown in (C), details as in Panel (B). Representative action 
potential duration map of ITA-treated heart are further shown (D). Panel E shows the 




typical for ventricular myocardial tissue.   Figure 34C shows a representative activation 
map for TA-treated heart with a small infarct.  The propagation of excitation is smooth 
with a propagation speed close to that of saline-treated hearts.  Note in particular that 
there is no propagation block or slowing of conduction in the vicinity of the infarct; both 
would be visible in an activation map as more abrupt transitions from dark to light.  
Figure 35D shows the distribution of action potential durations (APDs) in an TA-treated 
heart (same heart as in Panel B).  The APDs are highly uniform across the ventricle, and 
in particular, there is no change in APD around the infarct, another sign that the area 
around the infarct exhibits normal electrical activity.  All TA-treated (n=4) hearts tested 
exhibited activation maps and action potential maps consistent with the representative 
examples shown here, with no sign of impeded conduction or change in APD around the 
infarcts.      
 
9.8 TA remains at the site of injection 
An important question is whether TA that we injected remains at the injection site or 
flows back out of the tissue once the needle is remove or would flow back due to the 
muscle resistance. This was important to know because, the whole study was 
hypothesized on the basis that TA remains at the site of inject and plays the major role 
recruiting the cardiac stem cells and promoting angiogenesis at that site of injury.  We 
confirmed that the TA remains at the injection site, but because of an NDA, we are not 









In Figure 36, we show a control heart that was stained with TTC, The white areas on the 
sections are the area that remained unstained due to myocardial infarction.   
 
9.10 Discussion 
Studies have shown that the ejection fraction decreases while heart rate increase as soon 
as after the onset of the myocardial infarction symptoms[82], [83]. These 
echocardiograms measurements suggests that the presence of an infarct[81] in this heart.   
The echocardiogram data also show that TA is deliverable to the myocardium where it 
safely and significantly improves ejection fraction in rats with a moderately sized 
infarction, accomplished without creating electrically compromised tissue.  
 
Optical mapping experiments show that TA not only increases the amount of surviving 
tissue, but that this tissue is also fully functional from an electrophysiological point of 
Figure 36:  TTC stained heart assessed 8 weeks post control 




view. This finding is important, because insufficiently regenerated tissue could lead to 
slow conduction, changes in action potential duration, and unidirectional block, which 
could together provide a substrate for arrhythmias that could be even worse than a larger 
infarct. This is a notable concern as other approaches to regenerating myocardial tissue 
have reported aberrant electrical activity in the heart, including recent use of embryonic 
stem cell (ESC)-derived cardiomyocytes applied to a primate heart[84]. Since no 
electrophysiological abnormalities were seen in any of the TA injected hearts, it is 




With continued successful preclinical development, this work may lead to a potential 
therapeutic agent for myocardial infarction. TA has advantage because of its human 
tissue origin and has potential for delivery using minimal invasive surgery. Also, TA 
could reduce the immense pressures for organ transplantation and the use of external 
assist devices, both with their associated risky surgical procedures, and thus savings lives 









CONCLUSIONS AND FUTURE WORK 
In Chapter I, we showed that the geodesic, which predicts the shape of stationary 
filaments of scroll waves, is valid even for large filament curvatures and for abrupt 
changes in diffusivity, as long as these changes occur far enough from the filament.  Our 
finding greatly enhances the utility of the geodesic principle, and therefore contributes to 
the understanding of the mechanisms underlying ventricular fibrillation. 
 
The treatment of ventricular fibrillation was the subject of Chapters 2 - 5, in which we 
showed how nanosecond pulsed electric fields (nsPEFs) can be used to stimulate and 
defibrillate rabbit hearts. The nsPEF amplitude required to stimulate rabbit hearts lies in 
the range of 0.75 to 1 kV over a distance of 3 cm, while defibrillation required an 
amplitude of 2.3-2.4 kV over 3 cm.  This means that the energy required to defibrillate 
the rabbit heart with nsPEFs is eight times lower than the corresponding energy for 
millisecond defibrillation, which is a dramatic improvement.  
 
NsPEF application did not significantly affect the electrical activity of the heart: The 
action potential duration was unchanged, while the diastolic interval was affected, but 
only for a single beat after the nsPEF application.  Histological stains did not reveal any 
damage in the vicinity of the electrodes in a heart that had been exposed to a large 




Our future plans are to study the efficacy of nsPEF defibrillation for a variety of shock 
parameters and at the same time study the potential damage that nsPEFs may do in more 
detail.  Then we will move to a large animal model (pigs) to prepare a clinical trial and 
move nsPEF defibrillation to the clinical practice.  
 
In Chapters 5 – 7, we developed a rat model of myocardial infarction and, using this 
model, showed that an injectable therapeutic agent is effective in limiting the infarct size 
resulting from ligation of a coronary artery.  Successful creation of infarction was 
verified by echocardiography (using ejection fraction and heart rate). 
 
Injection of the therapeutic agent (TA) significantly reduced the drop in ejection fraction, 
a sign that the developed infarct was smaller.  The rise in heart rate associated with 
infarction was also reduced, although larger animal numbers will be necessary to 
establish significance of this result.  Optical mapping experiments showed no sign of 
arrhythmias in the vicinity of the infarction.  
 
To take TA as a treatment alternative for myocardial infarction to clinical levels will 
require studies on toxicity. Once the safety of TA has been proven in rats, we will study 
the efficacy of TA in large animals (pigs).  
 
In summary, this thesis presents new approaches to understanding cardiac arrhythmias, 




identified specific treatments that after further testing may become approved for clinical 
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